Previous studies showed that transforming growth factor Pl (TGFP1) regulates the expression of carcinoembryonic antigen (CEA) and CEA-cross-reactive glycoproteins (CEA-GLYs) in human colon carcinoma cells through a signal-transducing pathway associated with protein kinase C (PKC) (Chakrabarty, J. Ce
Role of protein kinase C in transforming growth factor-β1 induction of carcinoembryonic antigen in human colon carcinoma cells
✍ Scribed by Subhas Chakrabarty
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 699 KB
- Volume
- 152
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Transforming growth factor-pl (TGF-P1 ) regulates the expression of the carcinoembryonic antigen (CEA) gene family in the human colon carcinotna cell line Moscr. The mechanisms through which it acts, however, are unknown. In this communication, sevrral lines of evidence are presented to show that the induction of CEA expression and secretion (collectively called CEA response3) by TGF-p1 is associated with protein kinase C (PKC) pathway of signal transduction.
Trealnient of intact cells with the PKC-specific inhibitor calphostin C downmodulated cellular PKC phosphotransferase activity and blocked thc induction of the CEA responses by TGF-PI . Depletion of PKC by treatment of intact cells with phorbol ester also blocked the action of TGF-PI. The induction of the CEA responses by TGF-PI was also blocked by the protein kinase inhibitor 1 -(isoquin-
📜 SIMILAR VOLUMES
The human colon cancer cell lines HCT I I 6 (poorly differentiated) and GEO (well differentiated) express the mitogenic peptide transforming growth factor alpha (TGF-a). The secretion of TGF-awas enhanced by phorbol 12-myristate 13-acetate (PMA), indicating the possible role of protein kinase C (PKC
Transforming growth factor-␣ (TGF-␣) is synthesized as a membrane-bound precursor protein, pro-TGF-␣, that is converted to a soluble form by 2 endoproteolytic cleavages. Several factors have been implicated in the regulation of the second rate-limiting step, including protein kinase C (PKC). Earlier
Antibodies to epidermal-growth-factor receptor (EGF) and transforming growth factor-a (TGVa) were used to determine the role of endogenous TGF-a in the growth of 2 human colon-carcinoma cell lines. Both the GEO and HCT I 16 coloncarcinoma cell lines secrete similar levels of TGF-a and have similar n
Human colon carcinoma cell lines secrete transforminggrowth factor-a (TGF-a). Previous work indicated that the apparent m.w. of the TGF-a secreted by these cells ranged between 5 and 25 kDa. The more differentiated CEO cell line secreted a higher percentage of high m.w. TGF-a than did the poorly dif